Filed in archive
Treatment
by Gloria Gamat on March 29, 2006

Facial lipoatrophy or facial wasting, an additional complication in HIV treatments, may lead to anxiety, depression, self-image problems and difficulties in social or sexual relationships of the patients.
Changes in body fat distribution, including loss of subcutaneous fat in the face, may be a side effect of antiretroviral therapy and affect somewhere between 10 and 62 percent of individuals with HIV, the authors write.
The patients' facial atrophy began to improve after the second injection and remained visibly improved through the end of the follow-up period (12 months). Twelve months after the end of the treatment period, the total thickness of skin and fat increased an average of 3.4 millimeters over the right cheek and 3.3 millimeters over the left cheek.
Read more at Science Daily.
Tags:
facial
lipoatrophy
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/19103
Mr Wong
Vote for Injection of Synthetic Polymer May Relieve HIV Patients of Facial Lipoatrophy:
|
Rating: 7.67 out of 6 vote(s) cast.
|
Response from:
Trusted.MD Network
Subscribe
Use the search to look for other interesting posts
| RSS | See all blog subscribe options |
|
What is RSS? | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
| Newsletter | |
| Follow us on Twitter! |









